Daesung Shin PhD

Daesung Shin

Daesung Shin
PhD

Associate Professor

Department of Biotechnical and Clinical Laboratory Sciences

Jacobs School of Medicine & Biomedical Sciences


Specialty/Research Focus

Glia - Physiology & Pathophysiology; Lysosomal Storage Diseases; Myelin Diseases; Neurodevelopmental Disorders

Contact Information
313 Farber Hall
Buffalo, New York 14214
Phone: 716-829-5191
daesungs@buffalo.edu



Professional Summary:

Krabbe disease (KD), or globoid cell leukodystrophy, is a fatal neurodegenerative lysosomal storage disorder caused by a deficiency in galactosylceramidase (GALC), impacting both the central and peripheral nervous systems. Early-infantile KD typically manifests within the first few months of life with severe irritability, muscle rigidity, and rapid motor decline, inevitably progressing to terminal clinical decay within months. Currently, no cure exists.

Our understanding of KD pathogenesis remains limited, largely constrained by clinical observation and spontaneous animal models. While hematopoietic stem cell transplantation (HSCT) can partially attenuate disease progression, its efficacy is strictly limited to pre-symptomatic intervention. This therapy relies on cross-correction—the mechanism by which stem cell derivatives secrete functional GALC that is internalized by recipient glia via mannose-6-phosphate receptors. However, critical questions remain regarding the in vivo efficiency of cross-correction, the precise cell types requiring restoration, and the developmental window during which intervention must occur. Furthermore, while GALC deficiency causes toxic accumulation of the lysolipid psychosine—driving oligodendrocyte, Schwann cell, and neuronal death—the relative contribution of psychosine toxicity, its primary cellular sources, and the precise cascade of pathogenic events remain unresolved.

To address these critical gaps, we generated a novel conditional Galc floxed mouse allele. Utilizing targeted in vivo and in vitro conditional knockout models, we are elucidating the cell-autonomous and non-cell-autonomous mechanisms driving KD, as well as the mechanistic constraints of HSCT cross-correction. By dissecting both the primary loss-of-function defects and downstream secondary pathogenic pathways, our goal is to identify novel therapeutic targets for Krabbe disease and related neurodegenerative and demyelinating leukodystrophies.

Education and Training:

  • PhD, Neuroscience, Korea Advanced Institute of Science and Technology (2003)
  • MS, Genetics, Korea Advanced Institute of Science and Technology (1999)
  • BS, Biological Sciences, Korea Advanced Institute of Science and Technology (1997)

Employment:

  • Principal Investigator, Hunter James Kelly Research Institute (2011–2020)
  • Post Doctoral Fellow, Neurogenetics, University of California San Francisco / Howard Hughes Medical Institute (2005–2011)

Awards and Honors:

  • Travel Stipend Award - Gordon Conference (Lysosomal disease) (2019)
  • Young Investigator Award - Neurobiology of Disease in Children Symposium (2017)
  • Travel Fellowship Award - American Neurological Association (2010)

Grants and Sponsored Research:

  • December 2024–December 2029
    Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy
    NIH
    Role: Principal Investigator
    $2,013,407
  • November 2024–January 2027
    Modulating Oligodendroglial NFkB as a Therapeutic Strategy for Krabbe Disease
    The Rosenau Family Research Foundation
    Role: Principal Investigator
    $250,000
  • November 2025–October 2026
    Role of SERPINA3 in Krabbe leukodystrophy
    Research and Economic Development Grant Resubmission Program
    Role: Principal Investigator
    $15,000
  • June 2024–November 2025
    Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy
    SUNY Research Seed Grant Program
    Role: Principal Investigator
    $40,000
  • February 2019–January 2025
    The peripheral nervous system: A window into Krabbe disease
    NIH-NINDS
    Role: Co-Investigator
    $2,129,163
  • December 2019–November 2024
    Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy
    NIH-NINDS
    Role: Principal Investigator
    $1,395,624
  • December 2018–November 2019
    Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy
    NIH-NINDS
    Role: Principal Investigator
    $398,750
  • September 2014–August 2016
    Clinical variability and Cell autonomy of Krabbe leukodystrophy
    NIH-NINDS
    Role: Principal Investigator
    $159,084
  • July 2014–June 2015
    Study of clinical variability of Krabbe disease using oligodendrocytes differentiated from patient iPSCs
    New York Stem Cell Foundation
    Role: Principal Investigator
    $6,000

Journal Articles:

See all (13 more)

Abstracts:

  • Daesung Shin, Nadav Weinstock, M. Laura Feltri, and Lawrence Wrabetz. (2018) Temporal Galc deletion reveals a critical vulnerable period in the pathogenesis of Krabbe leukodystrophy. Mol. Genet. Metab, (Feb)

Presentations:

  • "NF-kB activation in oligodendrocytes attenuates interferon-gamma response and cell death in Krabbe leukodystrophy" Neurobiology of Brain Disorders, Gordon Research Conferences (2026)
  • "Cell autonomous roles of galactosylceramidase in Krabbe disease" Invited seminar, Chiesi Global Rare Diseases (2025)
  • "Cell-autonomous roles of galactosylceramidase and their contribution to Krabbe disease" Lysosomes Storage Diseases, Gordon Research Conferences (2025)
  • "Quest to cure Krabbe disease" Dyne Therapeutics, Inc. Invited Seminar (2024)
  • "Study on the molecular mechanisms of Krabbe Disease" Neuroscience program seminar, University at Buffalo (2024)
  • "Cell-autonomous roles of galactosylceramidase: Novel insights into the progression Krabbe disease" Lysosomes Storage Diseases, Gordon Research Conferences (2023)
  • "Molecular mechanisms and Preclinical study of Krabbe disease" BK21 International Symposium on Neurodegeneration (2023)
  • "Molecular pathogenesis of Krabbe leukodystrophy" Global Leukodystrophy Initiative Conference, Children’s Hospital of Philadelphia (2022)

Service Activities:

  • Special Emphasis Panel, NIH study section; ad hoc grant reviewer (2026)
  • Fondazione Telethon ETS; ad hoc grant reviewer (2026)
  • European Leukodystrophy Association International Research Grant; ad hoc grant reviewer (2026)
  • Biotechnical and Clinical Laboratory Sciences Staff; Search Committee (2026)
  • Krabbe Translational Research Network Round Table Workshops; Panel (2026)
  • Tenure, Promotion & Privileges Committee; Faculty Senator (2025–present)
  • European Leukodystrophy Association International Research Grant; ad hoc grant reviewer (2025)
  • 17th Annual Buffalo Neuroscience Research Day; Facilitator (2024)
  • UB Budget Priorities Committee; Faculty Senator (2024–2025)
  • Search Committee for a Biotechnical and Clinical Laboratory Sciences Staff; Committee (2024)
  • 16th Annual Buffalo Neuroscience Research Day; Judge (2023)
  • UK Research and Innovation; ad hoc grant reviewer (2023–present)
  • On-site Research discussion committee for MD-PhD candidates; Committee (2023)
  • Search Committee for a Biotechnical and Clinical Laboratory Sciences faculty; Committee (2023–2024)
  • 15th Annual Buffalo Neuroscience Research Day; Judge (2022)
  • Global Leukodystrophy Initiative; a key opinion leader (2022–present)
  • Select Committee on Graduate Educational Policies in Biomedical Sciences; Committee (2021–present)
  • Sanfilippo Foundation; ad hoc grant reviewer (2021–present)
  • Neuroscience program representative to the Faculty Council; Committee (2021–present)
  • Experimental Learning Network Program; Faculty Mentor (2021–present)
  • PhD Program in Biomedical Sciences - Admission Committee; Member (2020–present)
  • MS Program in Biotechnology - Admission Committee; Admission Committee (2020–present)
  • Undergraduate Program in Biotechnology - Admission Committee; Admission Committee (2020–present)
  • Biotechnology Undergraduate Program; Associate Program Director (2020–present)
  • Journal of Neuroscience / Journal of Neuroscience Research / Cerebral Cortex / Journal of Visualized Experiments / Journal of Inherited Metabolic Disease / Disease Models and Mechanisms / Brain Communications / International Journal of Molecular Sciences / PLoS Biology / Neurochemical Research; ad hoc reviewer (2015–present)

School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information

313 Farber Hall
Buffalo, New York 14214
Phone: 716-829-5191
daesungs@buffalo.edu